Cargando…

Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein

Hepatitis C virus (HCV) is the major cause of progressive liver disease such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Previously, we reported that a 29 nucleotide-long 2'-F pyrimidine modified RNA aptamer against the HCV nonstructural protein 5B efficiently inhibited HCV r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chang Ho, Lee, Soo-Han, Kim, Ji Hyun, Noh, Yook-Hwan, Noh, Gyu-Jeong, Lee, Seong-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881758/ https://www.ncbi.nlm.nih.gov/pubmed/26440598 http://dx.doi.org/10.1038/mtna.2015.30

Ejemplares similares

Development of an aptamer-conjugated fluorescent nanoprobe for MMP2
por: Han, Myoung-Eun, et al.
Publicado: (2014)

Exosomal Transmission of MicroRNA from HCV Replicating Cells Stimulates Transdifferentiation in Hepatic Stellate Cells
por: Kim, Ji Hyun, et al.
Publicado: (2019)

Recovery of TRIM25-Mediated RIG-I Ubiquitination through Suppression of NS1 by RNA Aptamers
por: Woo, Hye-Min, et al.
Publicado: (2019)

Performance of NS3, NS5a AND NS5b Hepatitis C Virus (HCV) Antiviral Resistance Sequencing Assays
por: Nutt, Jamie, et al.
Publicado: (2017)

Inhibition of Hepatitis C Virus Infection by DNA Aptamer against NS2 Protein
por: Gao, Yimin, et al.
Publicado: (2014)

Predictive performance of pharmacokinetic models for target concentration‐controlled infusion of cefoxitin as a prophylactic antibiotic in patients with colorectal surgery
por: Kang, Hyun‐Uk, et al.
Publicado: (2022)

Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection
por: Sillanpää, Maarit, et al.
Publicado: (2009)

Identification of NS2 determinants stimulating intrinsic HCV NS2 protease activity
por: Isken, Olaf, et al.
Publicado: (2022)

Anticancer effect of locally applicable aptamer‐conjugated gemcitabine‐loaded atelocollagen patch in pancreatic cancer patient–derived xenograft models
por: Hong, Seung Soo, et al.
Publicado: (2022)

Generation of hepatitis C virus–resistant liver cells by genome editing–mediated stable expression of RNA aptamer
por: Kim, Tae Hyeong, et al.
Publicado: (2023)

Aptamers for Anti-Viral Therapeutics and Diagnostics
por: Kim, Tae-Hyeong, et al.
Publicado: (2021)

Changes in the Serum Level of High Density Lipoprotein-cholesterol after Smoking Cessation among Adult Men
por: Noh, Jung-Mun, et al.
Publicado: (2012)

Dose proportionality and pharmacokinetics of carvedilol sustained-release formulation: a single dose-ascending 10-sequence incomplete block study
por: Kim, Yo Han, et al.
Publicado: (2015)

PrP(C) Aptamer Conjugated–Gold Nanoparticles for Targeted Delivery of Doxorubicin to Colorectal Cancer Cells
por: Go, Gyeongyun, et al.
Publicado: (2021)

Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naïve patients infected with HCV genotype 1 in Tunisia
por: Aissa Larousse, Jameleddine, et al.
Publicado: (2015)

Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy
por: Jeong, Hwa Yeon, et al.
Publicado: (2020)

Using modified aptamers for site specific protein–aptamer conjugations
por: Wang, Ruowen, et al.
Publicado: (2016)

Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
por: Demetriou, Victoria L, et al.
Publicado: (2010)

Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent
por: Kwon, Hyock Joo, et al.
Publicado: (2015)

Determination of Leuprolide–Fatty Acid Conjugate in Rat Plasma Using LC-MS/MS and Its Pharmacokinetics after Subcutaneous Administration in Rats
por: Seong, Gi-Sang, et al.
Publicado: (2022)

Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles
por: Kim, Min Woo, et al.
Publicado: (2017)

Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease
por: El-Araby, Moustafa E., et al.
Publicado: (2020)

The Future of HCV Therapy: NS4B as an Antiviral Target
por: Dvory-Sobol, Hadas, et al.
Publicado: (2010)

VAPC, an Human Endogenous Inhibitor for Hepatitis C Virus (HCV) Infection, Is Intrinsically Unstructured but Forms a “Fuzzy Complex” with HCV NS5B
por: Goyal, Shaveta, et al.
Publicado: (2012)

Cell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5A
por: Cai, Hua, et al.
Publicado: (2016)

Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C
por: Costantino, Angela, et al.
Publicado: (2015)

A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
por: Isken, Olaf, et al.
Publicado: (2015)

Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling
por: Ban, Junsu, et al.
Publicado: (2018)

A hotspot for enhancing insulin receptor activation revealed by a conformation-specific allosteric aptamer
por: Yunn, Na-Oh, et al.
Publicado: (2021)

Antioxidative and Cholesterol-Lowering Effects of Lemon Essential Oil in Hypercholesterolemia-Induced Rabbits
por: Lee, Hyunjoo, et al.
Publicado: (2018)

Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization
por: Lang Kuhs, Krystle A., et al.
Publicado: (2012)

Correction: A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
por: Isken, Olaf, et al.
Publicado: (2016)

Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function
por: Saalau-Bethell, Susanne M., et al.
Publicado: (2012)

Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
por: Lee, Yun Bin, et al.
Publicado: (2018)

The comparison of predictive performance in bispectral index prediction during target effect-site controlled infusion of propofol using different blood effect-site equilibration rate constants in the same pharmacokinetic model
por: Choi, Byung-Moon, et al.
Publicado: (2013)

Interferon Alpha Therapy in Patients with Chronic Type C Hepatitis: Changes of Serum ALT, Anti-HCV & HCV-RNA
por: Cho, Ho Jun, et al.
Publicado: (1992)

trans-Complementation of an NS2 Defect in a Late Step in Hepatitis C Virus (HCV) Particle Assembly and Maturation
por: Yi, MinKyung, et al.
Publicado: (2009)

Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients
por: Sadri, Mahrou, et al.
Publicado: (2015)

Simultaneous Imaging of Two Different Cancer Biomarkers Using Aptamer-Conjugated Quantum Dots
por: Lee, Jonghwan, et al.
Publicado: (2015)

Correction: Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization
por: Lang Kuhs, Krystle A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s6666ntfjc29fldneknhmp6ljk